Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
Open Access
- 6 May 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (9), 3301
- https://doi.org/10.3390/ijms21093301
Abstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease; it is characterized by the loss of dopaminergic neurons in the midbrain and the accumulation of neuronal inclusions, mainly consisting of α-synuclein (α-syn) fibrils in the affected regions. The prion-like property of the pathological forms of α-syn transmitted via neuronal circuits has been considered inherent in the nature of PD. Thus, one of the potential targets in terms of PD prevention is the suppression of α-syn conversion from the functional form to pathological forms. Recent studies suggested that α-syn interacts with synaptic vesicle membranes and modulate the synaptic functions. A series of studies suggest that transient interaction of α-syn as multimers with synaptic vesicle membranes composed of phospholipids and other lipids is required for its physiological function, while an α-syn-lipid interaction imbalance is believed to cause α-syn aggregation and the resultant pathological α-syn conversion. Altered lipid metabolisms have also been implicated in the modulation of PD pathogenesis. This review focuses on the current literature reporting the role of lipids, especially phospholipids, and lipid metabolism in α-syn dynamics and aggregation processes.Funding Information
- Japan Society for the Promotion of Science (18K15376, 17H04049)
- Otsuka Pharmaceutical (N/A)
This publication has 161 references indexed in Scilit:
- Somatic alpha‐synuclein mutations in Parkinson's disease: Hypothesis and preliminary dataMovement Disorders, 2013
- Native α-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2/VAMP2eLife, 2013
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brainsAnnals of Neurology, 2012
- Absence of an Orphan Mitochondrial Protein, C19orf12, Causes a Distinct Clinical Subtype of Neurodegeneration with Brain Iron AccumulationAmerican Journal of Human Genetics, 2011
- Effects of Curvature and Composition on α-Synuclein Binding to Lipid VesiclesBiophysical Journal, 2010
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disordersActa Neuropathologica, 2010
- SNCA variants are associated with increased risk for multiple system atrophyAnnals of Neurology, 2009
- α-Synuclein Cooperates with CSPα in Preventing NeurodegenerationCell, 2005
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Conformational properties of α-synuclein in its free and lipid-associated statesJournal of Molecular Biology, 2001